Bank of America Securities analyst Robert Ohmes has reiterated their bullish stance on EYE stock, giving a Buy rating today.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Robert Ohmes has given his Buy rating due to a combination of factors, including stronger-than-expected quarterly earnings and solid same-store sales growth across key banners. He highlights that higher average transaction values, supported by pricing actions and robust demand from managed care customers, are offsetting weaker traffic from cash-paying consumers, while gross margin is expanding on favorable pricing and product mix despite higher optometrist costs.
Ohmes also points to meaningful operating margin upside driven by SG&A leverage and a multi-year cost savings program, which underpin his above-midpoint EPS outlook for 2026. In addition, he sees the merchandising and CRM strategy—such as Meta AI glasses rollout, premium lens and branded frame penetration targets, and enhanced digital engagement—supporting share gains and sustained sales and earnings growth, which justifies his $35 price objective based on projected 2027 EBITDA.
In another report released today, Citi also assigned a Buy rating to the stock with a $40.00 price target.